Trial Profile
Double blind randomized placebo controlled study by virtual histology on the influence of oral pioglitazone for 9 month on the development of coronary plaques in non-diabetic patients with coronary heart disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 01 Jun 2011 New trial record